McDermott David M, Seldomridge Ashlee, Maniar Ashray, Mattes Malcolm D
Department of Radiation Oncology, West Virginia University, Morgantown, WV, USA.
West Virginia University School of Medicine, Morgantown, WV, USA.
Ann Palliat Med. 2020 Sep;9(5):3513-3521. doi: 10.21037/apm-20-462. Epub 2020 Aug 27.
Early palliative care (PC) physician involvement alongside standard oncologic care has been recommended by the American Society of Clinical Oncology (ASCO) guidelines for all advanced cancer patients, although adherence to these guidelines is variable. Radiation oncologists (ROs) could help facilitate early PC referral for patients treated with palliative radiation, particularly those with brain metastasis (BRM), and the aim of this study was to evaluate the circumstances of PC referral at our institution to better understand the multidisciplinary approaches to facilitate it.
Patients diagnosed with BRM from non-small cell lung cancer (NSCLC) from 2012 to 2018 whose primary RO and MO were at our institution were reviewed. Overall survival and time to PC consultation from the first oncologic visit following BRM diagnosis was determined using the KaplanMeier method. Mann-Whitney U and Chi-Squared assessed for predictive factors for shorter time to PC consultation. For these factors, the overall survival, rate of PC consultation, and PC setting was used to determine utilization of early PC.
Among 103 eligible patients, only 48% underwent a PC consultation in their lifetime, with the initial evaluation being as an outpatient for 37%, and within 1 month of death for 35%. Median survival from BRM diagnosis was 9.0 months. The median time from oncologic appointment to PC referral was 2.8 months, and from initial PC consultation to death was 1.6 months. Only more recent BRM diagnosis (2016-2018 vs. 2012-2015) was associated with shorter time to PC consultation (1.0 vs. 5.6 months, P=0.013), increased PC consult rate (60% vs. 42%, P=0.105), and increased outpatient PC consultation (56% vs. 26%, P=0.037).
The majority of patients did not undergo early PC consultation, though utilization has improved over time. As ROs are commonly involved in BRM management, they may be in a position to proactively support early PC consultations in this patient population.
美国临床肿瘤学会(ASCO)指南建议,对于所有晚期癌症患者,在标准肿瘤治疗的同时应尽早让姑息治疗(PC)医生参与,尽管对这些指南的遵循情况各不相同。放射肿瘤学家(ROs)可以帮助促进接受姑息性放疗的患者,尤其是那些有脑转移(BRM)的患者尽早转诊至PC,本研究的目的是评估我院PC转诊的情况,以更好地了解促进转诊的多学科方法。
回顾了2012年至2018年在我院诊断为非小细胞肺癌(NSCLC)脑转移且主要RO和MO均在我院的患者。采用Kaplan-Meier方法确定从BRM诊断后的首次肿瘤就诊到PC会诊的总生存期和时间。使用Mann-Whitney U检验和卡方检验评估PC会诊时间较短的预测因素。对于这些因素,使用总生存期、PC会诊率和PC设置来确定早期PC的利用率。
在103例符合条件的患者中,只有48%的患者在其一生中接受了PC会诊,其中37%的患者首次评估是在门诊进行,35%的患者是在死亡前1个月内进行。从BRM诊断开始的中位生存期为9.0个月。从肿瘤预约到PC转诊的中位时间为2.8个月,从首次PC会诊到死亡的中位时间为1.6个月。只有最近的BRM诊断(2016 - 2018年与2012 - 2015年)与较短的PC会诊时间(1.0个月对5.6个月,P = 0.013)、更高的PC会诊率(60%对42%,P = 0.105)以及更高的门诊PC会诊率(56%对26%,P = 0.037)相关。
大多数患者没有尽早接受PC会诊,尽管随着时间的推移利用率有所提高。由于ROs通常参与BRM的管理,他们可能有能力在这一患者群体中积极支持早期PC会诊。